Qualigen Therapeutics, Inc.
US ˙ NasdaqCM ˙ US74754R2022

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Matthew W Foehr. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Matthew W Foehr har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:OABI / OmniAb, Inc. President and CEO, Director 4.341.987
US:VKTX / Viking Therapeutics, Inc. Director 132.036
US:LGND / Ligand Pharmaceuticals Incorporated 162.187
CLO & Secretary, Director 0
US:RTTR / Ritter Pharmaceuticals, Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Matthew W Foehr. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb QLGN / Qualigen Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i QLGN / Qualigen Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-08-17 RTTR FOEHR MATTHEW W 19.751 2,0400 19.751 2,0400 40.292 19
2018-08-17 RTTR FOEHR MATTHEW W 19.751 2,0400 19.751 2,0400 40.292
2017-05-18 RTTR FOEHR MATTHEW W 18.000 0,6197 18.000 0,6197 11.155
2016-01-08 RTTR FOEHR MATTHEW W 13.000 1,6400 13.000 1,6400 21.320
2015-06-24 RTTR FOEHR MATTHEW W 4.000 5,0000 4.000 5,0000 20.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

QLGN / Qualigen Therapeutics, Inc. Insider Trades
Insidersalg QLGN / Qualigen Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i QLGN / Qualigen Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

QLGN / Qualigen Therapeutics, Inc. Insider Trades
Insiderkøb VKTX / Viking Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i QLGN / Qualigen Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-05-02 VKTX FOEHR MATTHEW W 45.000 2,4710 45.000 2,4710 111.195 364 22.1200 884.205 795,18
2021-06-10 VKTX FOEHR MATTHEW W 20.000 5,6900 20.000 5,6900 113.800
2016-11-15 VKTX FOEHR MATTHEW W 13.000 1,2060 13.000 1,2060 15.678
2016-04-13 VKTX FOEHR MATTHEW W 20.000 1,2400 20.000 1,2400 24.800
2015-05-04 VKTX FOEHR MATTHEW W 6.250 8,0000 6.250 8,0000 50.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VKTX / Viking Therapeutics, Inc. Insider Trades
Insidersalg VKTX / Viking Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i QLGN / Qualigen Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-06-30 VKTX FOEHR MATTHEW W 13.000 7,3500 13.000 7,3500 95.550 330 5.19 -28.080 -29,39

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VKTX / Viking Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Matthew W Foehr som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-26 2025-08-26 4 OABI OmniAb, Inc.
Common Stock
A - Award 540.540 4.341.987 14,22 1,85 999.999 8.032.676
2025-04-14 2025-04-11 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
M - Exercise 20.786 132.036 18,68 8,00 166.288 1.056.288
2025-04-07 2025-04-07 4 OABI OmniAb, Inc.
Common Stock
S - Sale -19.382 3.796.236 -0,51 2,00 -38.764 7.592.472
2025-04-07 2025-04-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 36.458 3.815.618 0,96
2025-02-19 2025-02-19 4 OABI OmniAb, Inc.
Common Stock
S - Sale -19.522 3.779.160 -0,51 3,67 -71.646 13.869.517
2025-02-19 2025-02-18 4 OABI OmniAb, Inc.
Common Stock
S - Sale -13.964 3.798.682 -0,37 3,68 -51.388 13.979.150
2025-02-19 2025-02-16 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 36.458 3.812.646 0,97
2025-02-19 2025-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 26.549 3.776.188 0,71
2025-01-22 2025-01-21 4 OABI OmniAb, Inc.
Common Stock
S - Sale -41.811 3.749.639 -1,10 3,24 -135.468 12.148.830
2025-01-22 2025-01-17 4 OABI OmniAb, Inc.
Common Stock
A - Award 77.003 3.791.450 2,07
2024-12-10 2024-12-09 4 OABI OmniAb, Inc.
Common Stock
S - Sale -13.634 3.714.447 -0,37 4,13 -56.308 15.340.666
2024-12-10 2024-12-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 26.555 3.728.081 0,72
2024-11-26 2024-11-25 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 68.360 3.698.600 1,88 3,75 256.350 13.869.750
2024-11-26 2024-11-25 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 31.074 3.630.240 0,86 3,68 114.352 13.359.283
2024-06-27 2024-06-27 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 41.015 3.599.166 1,15 3,75 153.806 13.496.872
2024-06-27 2024-06-27 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 18.644 3.558.151 0,53 3,68 68.610 13.093.996
2024-05-28 2024-05-24 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 240.000 3.536.665 7,28 4,42 1.059.840 15.617.913
2024-04-23 2022-11-01 4/A OABI OmniAb, Inc.
Common Stock
A - Award 1.431.618 3.296.665 76,76
2024-04-09 2024-04-07 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -18.477 3.170.397 -0,58 5,31 -98.113 16.834.808
2024-04-09 2024-04-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 36.458 3.188.874 1,16
2024-03-29 2024-03-27 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 150.391 3.152.416 5,01 3,75 563.966 11.821.560
2024-03-29 2024-03-27 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 93.222 3.002.025 3,20 3,68 343.057 11.047.452
2024-03-25 2024-03-22 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 225.000 2.908.803 8,38 5,19 1.167.750 15.096.688
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -13.460 2.683.803 -0,50 5,54 -74.568 14.868.269
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 26.558 2.697.263 0,99
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -5.459 2.670.705 -0,20 5,54 -30.243 14.795.706
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 10.770 2.676.164 0,40
2024-01-03 2024-01-02 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -13.221 2.665.394 -0,49 6,25 -82.631 16.658.712
2024-01-03 2024-01-02 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 33.173 2.678.615 1,25
2023-12-13 2023-12-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 200.000 2.645.442 8,18 5,05 1.010.000 13.359.482
2023-12-11 2023-12-07 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -9.184 2.445.442 -0,37 4,85 -44.542 11.860.394
2023-12-11 2023-12-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 26.556 2.454.626 1,09
2023-11-13 2023-11-10 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 95.000 2.427.919 4,07 4,27 405.517 10.363.815
2023-08-15 2023-08-14 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 45.000 2.332.919 1,97 5,48 246.600 12.784.396
2023-06-12 2023-06-09 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 115.000 2.574.009 4,68 4,52 519.800 11.634.521
2023-05-15 2023-05-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 440.000 2.438.414 22,02 3,40 1.496.000 8.290.608
2023-04-11 2023-04-07 4 OABI OmniAb, Inc.
Common Stock
A - Award 109.375 1.998.414 5,79
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -4.177 1.889.039 -0,22 3,80 -15.873 7.178.348
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -3.725 1.893.216 -0,20 3,80 -14.155 7.194.221
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -9.184 1.896.941 -0,48 3,80 -34.899 7.208.376
2023-01-05 2023-01-03 4 OABI OmniAb, Inc.
Common Stock
A - Award 79.665 1.906.125 4,36
2022-12-30 2022-12-28 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -11.624 1.826.460 -0,63 3,66 -42.544 6.684.844
2022-12-14 2022-12-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 150.000 1.838.084 8,89 3,77 564.765 6.920.570
2022-12-05 2022-12-01 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -17.266 1.688.084 -1,01 3,35 -57.841 5.655.081
2022-12-01 2022-11-30 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 300.000 1.705.350 21,35 3,39 1.016.340 5.777.385
2022-11-09 2022-11-09 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 100.000 1.405.350 7,66 2,76 276.160 3.881.015
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -20.304 162.187 -11,13
2022-11-03 2022-11-01 4 NONE OmniAb Operations, Inc.
Common Stock
D - Sale to Issuer -212.362 0 -100,00
2022-11-03 2022-11-01 4 NONE OmniAb Operations, Inc.
Common Stock
A - Award 26.193 212.362 14,07
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 1.305.350 1.305.350
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.137 182.491 5,27
2022-05-13 2022-05-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.500 173.354 1,46 82,76 206.910 14.347.436
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 34.214 34.214
2022-05-03 2022-05-02 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
P - Purchase 45.000 111.250 67,92 2,47 111.195 274.899
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.090 170.854 -0,63 123,68 -134.811 21.131.223
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.222 171.944 -0,71 123,68 -151.137 21.266.034
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.234 173.166 -0,71 123,68 -152.621 21.417.171
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.188 174.400 -1,80 113,68 -362.412 19.825.792
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.937 177.588 -1,08 113,68 -220.198 20.188.204
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.396 179.525 4,30
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.604 172.129 3,37
2022-01-05 2022-01-03 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 22.000 22.000
2021-11-12 2021-11-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.028 24.348 -4,05
2021-11-12 2021-11-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -11.160 0 -100,00
2021-11-12 2021-11-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -11.160 166.525 -6,28 163,02 -1.819.255 27.146.189
2021-11-12 2021-11-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11.160 177.685 6,70 21,92 244.627 3.894.855
2021-11-12 2021-11-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.028 166.525 0,62 100,38 103.191 16.715.780
2021-08-05 2021-08-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.142 25.938 -4,22
2021-08-05 2021-08-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -8.840 11.160 -44,20
2021-08-05 2021-08-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.142 165.497 0,69 85,79 97.972 14.197.988
2021-08-05 2021-08-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -8.840 164.355 -5,10 109,67 -969.507 18.025.257
2021-08-05 2021-08-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 8.840 173.195 5,38 21,92 193.773 3.796.434
2021-06-10 2021-06-10 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
P - Purchase 20.000 66.250 43,24 5,69 113.800 376.962
2021-06-01 2021-05-28 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.755 40.358 -4,17
2021-06-01 2021-05-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.755 164.355 1,08 56,26 98.736 9.246.612
2021-06-01 2021-05-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -2.500 162.600 -1,51
2021-03-25 2021-03-22 4 VKTX Viking Therapeutics, Inc.
Warrants (Right to Buy)
X - Other -20.000 0 -100,00
2021-03-25 2021-03-22 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
X - Other 20.000 46.250 76,19 1,50 30.000 69.375
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.222 165.100 -0,73 172,46 -210.746 28.473.146
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.235 166.322 -0,74 172,46 -212.988 28.683.892
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -641 167.557 -0,38 172,46 -110.547 28.896.880
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.000 63.210 -1,56
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -44.547 20.000 -69,01
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -44.547 168.198 -20,94 176,86 -7.878.582 29.747.498
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 44.547 212.745 26,48 21,92 976.470 4.663.370
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 168.198 0,60 74,42 74.420 12.517.295
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 13.136 13.136
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.595 167.198 4,11
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.272 160.603 -1,39 156,01 -354.455 25.055.674
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.604 162.875 3,56
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.053 157.271 -0,67 156,01 -164.279 24.535.849
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.911 158.324 1,87
2021-01-06 2021-01-04 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 22.000 22.000
2020-08-25 2020-08-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -78 64.547 -0,12
2020-08-25 2020-08-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -78 155.413 -0,05 110,89 -8.649 17.233.748
2020-08-25 2020-08-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 78 155.491 0,05 21,92 1.710 3.408.363
2020-08-25 2020-08-21 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -790 64.210 -1,22
2020-08-25 2020-08-21 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -7.225 0 -100,00
2020-08-25 2020-08-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -7.225 155.413 -4,44 112,88 -815.541 17.542.646
2020-08-25 2020-08-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.225 162.638 4,65 14,47 104.546 2.353.372
2020-08-25 2020-08-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 790 155.413 0,51 74,42 58.792 11.565.835
2020-06-30 2020-06-30 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
S - Sale -13.000 26.250 -33,12 7,35 -95.550 192.938
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -642 122.727 -0,52 120,86 -77.592 14.832.785
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.246 123.369 -1,00 120,86 -150.592 14.910.377
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -938 124.615 -0,75 120,86 -113.367 15.060.969
2020-04-23 2020-04-10 4 RTTR RITTER PHARMACEUTICALS INC
Warrant Shares (right to buy)
D - Sale to Issuer -38.461 0 -100,00
2020-04-23 2020-04-10 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
A - Award 38.461 138.635 38,39
2020-04-23 2020-01-21 4 RTTR RITTER PHARMACEUTICALS INC
Series B convertible preferred stock
C - Conversion -100 0 -100,00
2020-04-23 2020-01-21 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
C - Conversion 76.923 100.174 330,84
2020-03-13 2020-03-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.000 64.625 -3,00
2020-03-13 2020-03-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 157.449 1,29 21,92 43.840 3.451.282
2020-02-27 2020-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.706 66.625 -2,50
2020-02-27 2020-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -7.225 7.225 -50,00
2020-02-27 2020-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.706 155.449 1,11 21,92 37.396 3.407.442
2020-02-27 2020-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -7.225 153.743 -4,49 110,00 -794.750 16.911.730
2020-02-27 2020-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.225 160.968 4,70 14,47 104.546 2.329.207
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.170 153.743 -0,76 97,23 -113.759 14.948.432
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -447 154.913 -0,29 97,23 -43.462 15.062.191
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -869 155.360 -0,56 97,23 -84.493 15.105.653
2020-02-18 2020-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -7.225 14.450 -33,33
2020-02-18 2020-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -7.225 156.229 -4,42 95,84 -692.467 14.973.487
2020-02-18 2020-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.225 163.454 4,62 14,47 104.546 2.365.179
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 33.210 33.210
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -496 68.331 -0,72
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.396 156.229 4,97
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 496 148.833 0,33 21,92 10.872 3.262.419
2020-01-17 2020-01-15 4 RTTR RITTER PHARMACEUTICALS INC
Non-qualified Stock Option (Right to Buy)
A - Award 12.000 12.000
2020-01-03 2020-01-02 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 22.000 22.000
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.444 148.337 -0,96 105,87 -152.876 15.704.438
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.913 149.781 1,98
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.210 146.868 -1,48 105,87 -233.973 15.548.915
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4.458 149.078 3,08
2019-11-13 2019-11-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.001 68.827 -1,43
2019-11-13 2019-11-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.001 144.620 0,70 21,92 21.942 3.170.070
2019-09-05 2019-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.005 69.828 -1,42
2019-09-05 2019-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.005 143.619 0,70 21,92 22.030 3.148.128
2019-08-13 2019-08-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.163 70.833 -1,62
2019-08-13 2019-08-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.163 142.614 0,82 21,92 25.493 3.126.099
2019-06-12 2019-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.004 71.996 -1,38
2019-06-12 2019-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.004 141.451 0,71 21,92 22.008 3.100.606
2019-03-15 2019-03-14 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -14.894 15.001 -49,82
2019-03-15 2019-03-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 14.894 140.447 11,86 9,97 148.493 1.400.257
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 34.181 34.181
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.472 125.553 6,33
2019-02-08 2019-02-06 4 RTTR RITTER PHARMACEUTICALS INC
Non-qualified Stock Option (Right to Buy)
A - Award 15.000 15.000
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.284 118.081 -1,08 111,78 -143.526 13.199.094
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.284 118.081 -1,08 111,78 -143.526 13.199.094
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.715 119.365 3,21
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.547 116.934 3,13
2019-01-03 2019-01-02 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 22.000 22.000
2018-12-12 2018-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -7.999 29.895 -21,11
2018-12-12 2018-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7.999 113.387 7,59 9,97 79.750 1.130.468
2018-11-07 2018-11-05 4 RTTR RITTER PHARMACEUTICALS INC
Warrant Shares (right to buy)
P - Purchase 38.461 38.461
2018-11-07 2018-11-05 4 RTTR RITTER PHARMACEUTICALS INC
Series B convertible preferred stock
P - Purchase 100 100
2018-10-02 2018-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -12.000 21.675 -35,63
2018-10-02 2018-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.088 37.894 -5,22
2018-10-02 2018-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.000 105.388 -10,22 273,88 -3.286.560 28.863.665
2018-10-02 2018-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.000 117.388 11,39 14,47 173.640 1.698.604
2018-10-02 2018-10-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.088 105.388 2,02 9,97 20.817 1.050.718
2018-09-19 2018-08-17 4/A RTTR RITTER PHARMACEUTICALS INC
Common Stock
P - Purchase 19.751 23.251 564,31 2,04 40.292 47.432
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -12.000 33.675 -26,27
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.044 39.982 -2,54
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.000 103.300 -10,41 255,01 -3.060.082 26.342.202
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.000 115.300 11,62 14,47 173.640 1.668.391
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.044 103.300 1,02 9,97 10.409 1.029.901
2018-08-20 2018-08-17 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
P - Purchase 19.751 54.751 56,43 2,04 40.292 111.692
2018-05-11 2018-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -8.881 45.675 -16,28
2018-05-11 2018-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.055 41.026 -2,51
2018-05-11 2018-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.055 102.256 1,04 9,97 10.518 1.019.492
2018-05-11 2018-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -8.881 101.201 -8,07 167,63 -1.488.687 16.963.919
2018-05-11 2018-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 8.881 110.082 8,78 14,47 128.508 1.592.887
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.457 101.201 -1,42 165,87 -241.673 16.786.210
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.940 102.658 2,95
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 20.274 20.274
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.883 99.718 4,05
2018-02-27 2018-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -5.444 54.556 -9,07
2018-02-27 2018-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.004 42.081 -2,33
2018-02-27 2018-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5.444 95.835 -5,38 152,98 -832.824 14.660.848
2018-02-27 2018-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5.444 101.279 5,68 14,47 78.775 1.465.507
2018-02-27 2018-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.004 95.835 1,06 9,97 10.010 955.475
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.246 94.831 -1,30 157,18 -195.846 14.905.537
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -906 96.077 -0,93 157,18 -142.405 15.101.383
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.511 96.983 -1,53 157,18 -237.499 15.243.788
2018-01-25 2018-01-23 4 RTTR RITTER PHARMACEUTICALS INC
Non-qualified Stock Option (Right to Buy)
A - Award 30.000 30.000
2018-01-03 2018-01-02 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16.000 16.000
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.971 98.494 -2,93 138,66 -411.959 13.657.178
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.695 101.465 5,95
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -850 43.085 -1,93
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -6.100 43.935 -12,19
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 850 95.770 0,90 9,97 8.474 954.827
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.100 94.920 -6,04 127,51 -777.824 12.103.449
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.100 101.020 6,43 9,97 60.817 1.007.169
2017-05-18 2017-05-18 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
P - Purchase 18.000 35.000 105,88 0,62 11.155 21.690
2017-05-15 2017-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.200 50.035 -4,21
2017-05-15 2017-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.200 94.920 2,37 9,97 21.934 946.352
2017-05-15 2017-05-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -5.621 52.235 -9,72
2017-05-15 2017-05-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5.621 92.720 -5,72 112,20 -630.650 10.402.757
2017-05-15 2017-05-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5.621 98.341 6,06 9,97 56.041 980.460
2017-03-03 2017-03-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.000 57.856 -3,34
2017-03-03 2017-03-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 92.720 2,20 9,97 19.940 924.418
2017-03-03 2017-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -6.879 59.856 -10,31
2017-03-03 2017-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.879 90.720 -7,05 103,39 -711.214 9.379.459
2017-03-03 2017-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.879 97.599 7,58 9,97 68.584 973.062
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25.376 25.376
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.544 90.720 9,07
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.733 83.176 -3,18 100,38 -274.339 8.349.207
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.239 85.909 6,49
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -725 80.670 -0,89 104,28 -75.603 8.412.268
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.642 81.395 -1,98 104,28 -171.228 8.487.871
2017-01-05 2017-01-03 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16.000 16.000
2016-11-30 2016-11-29 4 RTTR RITTER PHARMACEUTICALS INC
Stock Option (2015 Equity Incentive Plan)
A - Award 7.000 7.000
2016-11-15 2016-11-15 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
P - Purchase 13.000 39.250 49,52 1,21 15.678 47.336
2016-08-09 2016-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -4.125 66.735 -5,82
2016-08-09 2016-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.125 83.037 5,23 9,97 41.126 827.879
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -12.500 70.860 -15,00
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -12.500 78.912 -13,67 122,14 -1.526.750 9.638.312
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 91.412 15,84 9,97 124.625 911.378
2016-04-13 2016-04-13 4 VKTX Viking Therapeutics, Inc.
Warrants (Right to Buy)
P - Purchase 20.000 20.000 0,01 200 200
2016-04-13 2016-04-13 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001
P - Purchase 20.000 26.250 320,00 1,24 24.800 32.550
2016-03-17 2016-03-17 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.250 83.360 -2,63
2016-03-17 2016-03-17 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -6.400 85.610 -6,96
2016-03-17 2016-03-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.250 78.912 2,93 9,97 22.432 786.753
2016-03-17 2016-03-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.400 76.662 -7,71 96,70 -618.880 7.413.215
2016-03-17 2016-03-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.400 83.062 8,35 9,97 63.808 828.128
2016-02-16 2016-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.642 76.662 -2,10 85,97 -141.163 6.590.632
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 27.080 27.080
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.676 78.304 7,82
2016-01-11 2016-01-08 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
P - Purchase 13.000 17.000 325,00 1,64 21.320 27.880
2016-01-06 2016-01-04 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 16.000 16.000
2015-10-15 2015-10-13 4 RTTR RITTER PHARMACEUTICALS INC
Stock Option (2015 Equity Incentive Plan)
A - Award 10.000 10.000
2015-06-30 2015-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.500 92.010 -2,65
2015-06-30 2015-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 72.628 3,56 9,97 24.925 724.101
2015-06-30 2015-06-26 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -12.500 94.510 -11,68
2015-06-30 2015-06-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.500 70.128 -15,13 100,97 -1.262.125 7.080.824
2015-06-30 2015-06-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.500 82.628 17,82 9,97 124.625 823.801
2015-06-25 2015-06-24 4 RTTR RITTER PHARMACEUTICALS INC
Common Stock
P - Purchase 4.000 4.000 5,00 20.000 20.000
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -2.000 107.010 -1,83
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -23.046 109.010 -17,45
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 70.128 2,94 9,97 19.940 699.176
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -3.355 68.128 -4,69 97,47 -327.012 6.640.436
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -15.145 71.483 -17,48 96,43 -1.460.432 6.893.106
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4.546 86.628 -4,99 95,77 -435.370 8.296.364
2015-06-24 2015-06-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 23.046 91.174 33,83 9,97 229.769 909.005
2015-05-05 2015-05-04 4 VKTX Viking Therapeutics, Inc.
Common Stock, par value $0.00001 per share
P - Purchase 6.250 6.250 8,00 50.000 50.000
2015-04-30 2015-04-28 4 VKTX Viking Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 20.786 20.786
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 42.113 42.113 56,26 2.369.277 2.369.277
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13.112 68.128 23,83
2015-01-05 2014-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 46 55.016 0,08 45,23 2.081 2.488.291
2014-10-14 2014-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.000 132.056 -0,75
2014-10-14 2014-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 54.970 1,85 9,97 9.970 548.051
2014-10-14 2014-10-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 85 53.970 0,16 44,91 3.817 2.423.793
2014-07-01 2014-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 428 53.885 0,80 43,79 18.743 2.359.732
2014-02-14 2014-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -22.500 133.056 -14,46
2014-02-14 2014-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3.444 155.556 -2,17
2014-02-14 2014-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -22.500 53.457 -29,62 79,54 -1.789.650 4.251.970
2014-02-14 2014-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 22.500 75.957 42,09 9,97 224.325 757.291
2014-02-14 2014-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3.444 53.457 6,89 9,97 34.337 532.966
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 65.000 18,18 74,42 744.200 4.837.300
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 65.000 18,18 74,42 744.200 4.837.300
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 45.000 45.000 74,42 3.348.900 3.348.900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.000 50.013 11,11
2014-01-02 2013-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 84 45.013 0,19 33,92 2.849 1.526.616
2013-12-13 2013-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -6.000 159.000 -3,64
2013-12-13 2013-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.000 44.929 -11,78 53,40 -320.400 2.399.209
2013-12-13 2013-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.000 50.929 13,35 9,97 59.820 507.762
2013-07-01 2013-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.059 44.929 2,41 17,36 18.384 779.967
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8.333 43.870 23,45
2013-06-04 2011-04-18 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 51.546 51.546 9,97 513.914 513.914
2013-06-04 2011-04-18 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 16.667 16.667
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 64.625 64.625 21,92 1.416.580 1.416.580
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 8.375 8.375 21,92 183.580 183.580
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.000 43.870 15,84
2012-12-05 2012-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 370 37.870 0,99 17,99 6.656 681.224
2012-07-03 2012-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.250 37.500 3,45 10,12 12.654 379.631
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 60.000 60.000 14,47 868.200 868.200
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10.000 36.250 38,10
2012-01-06 2011-12-30 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.250 26.250 5,00 10,09 12.612 264.849
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)